Riskpilot← Back to searchSign inGet full accessLinnékliniken AB
ABActiveOrg 5568993504Linnégatan 5Dental practice care activities · NACE 8623Est. 20128 employees
Revenue 2024
SEK 10,7M
+24% vs 2023
EBITDA margin
8.0%
+413% vs 2023
Equity ratio
72.7%
Financial strength
Net profit 2024
SEK 629K
+20867% vs 2023
| Revenue | SEK 10,7M | +24% |
| EBITDA | SEK 860K | +413% |
| Net profit | SEK 629K | +20867% |
| Total assets | SEK 4,9M | +17% |
| Equity | SEK 3,5M | +22% |
| Employees | 8 | — |
Legal name
Linnékliniken AB
Org number
5568993504
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
19 juli 2012
Share capital
SEK 50 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Tandläkarverksamhet.
Address
Linnégatan 5
Phone
+46735262214
Email
info@linnekliniken.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 936 | 6 760 | 7 490 | 8 666 | 10 705 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 262 | 897 | 432 | −275 | 860 |
| Depreciation & amort. | −78 | −66 | −91 | −156 | −163 |
| EBIT | 184 | 831 | 341 | −431 | 697 |
| Net financials | 2 | 3 | 26 | 29 | 96 |
| Profit before tax | 186 | 633 | 367 | 14 | 794 |
| Tax | −41 | −131 | −78 | −11 | −165 |
| Net profit | 145 | 502 | 289 | 3 | 629 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 738 | 4 201 | 4 696 | 4 178 | 4 883 |
| Equity | 2 126 | 2 629 | 2 917 | 2 920 | 3 549 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 302 | 1 062 | 1 269 | 1 163 | 1 239 |
| Total debt | 1 302 | 1 062 | 1 269 | 1 163 | 1 239 |
EBITDA margin
8.0%
This company
15.8%
Market median
-49% vs market
20202024
Equity ratio
72.7%
This company
38.2%
Market median
+90% vs market
20202024
Return on equity
17.7%
This company
18.4%
Market median
+4% vs market
20202024
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
20202024
Asset turnover
2.19×
This company
1.12×
Market median
+96% vs market
20202024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LV | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Linnékliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lennart Victor Lindelöf | Audit | 0 companies |
| Enith Rua Bejarano | Deputy Board Member | 0 companies |
| Maya Britt Cauthin Rua Järvsén | Board of Directors | 0 companies |
| Robin Jonas Järvsén | Chairman | 0 companies |
| Jonas Robin Järvsén | Deputy Board Member | 0 companies |